Novartis Open Source Initiative
- 235 followers
- Cambridge, MA
- open.source@novartis.com
Pinned Loading
Repositories
- OncoBayes2 Public
Bayesian logistic regression with optional EX/NEX modeling enables flexible borrowing from historical or concurrent data. The safety model supports dose-escalation in adaptive Phase I oncology trials with multiple drugs. See Neuenschwander et al. (2008, 2016) for methodology.
Novartis/OncoBayes2’s past year of commit activity - synthetic-mris Public
This project demonstrates how to train a model that can generate synthetic brain (T1w) MRI data. The work was presented as a poster at ICAART 2025. Our code trains a Hierarchical Amortized GAN (HAGAN) model for 3D high resolution medical image synthesis of healthy subjects in MNI space.
Novartis/synthetic-mris’s past year of commit activity - tinydenseR Public
tinydenseR is a landmark-based platform for single cell data analysis that identifies differentially abundant cell types and differentially expressed features, including subtle within-cluster state changes. Modeling samples as replicates, tinydenseR enhances analytic efficiency and reproducibility while preserving the richness of single cell data
Novartis/tinydenseR’s past year of commit activity - singleCellComic Public
singeCellComic is an interactive Shiny application designed to teach the fundamental concepts of single-cell RNA sequencing (scRNA-seq) analysis through a fun, story-driven, and visual narrative.
Novartis/singleCellComic’s past year of commit activity - cellxgene-gateway Public
Cellxgene Gateway allows you to use the Cellxgene Server provided by the Chan Zuckerberg Institute (https://github.com/chanzuckerberg/cellxgene) with multiple datasets.
Novartis/cellxgene-gateway’s past year of commit activity - subgroup_shrinkage Public
Bayesian subgroup shrinkage estimation benchmark comparing various shrinkage models.
Novartis/subgroup_shrinkage’s past year of commit activity - Pipeline_for_TES_AAV_LongReads Public
This pipeline is designed for AAV integration site analysis using Target Enrichment Sequencing (TES) coupled with PacBio long-read sequencing. It enables the detection of integration site breakpoints and provides information on the structure of the integrated AAV vector genome to support the safety assessment of AAV-based gene therapies.
Novartis/Pipeline_for_TES_AAV_LongReads’s past year of commit activity